Allergan Inc
AGN
AGN was delisted on the 16th of March, 2015.
23 hedge funds and large institutions have $22.3M invested in Allergan Inc in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
18% less funds holding
Funds holding: 28 → 23 (-5)
42% less capital invested
Capital invested by funds: $38.4M → $22.3M (-$16.1M)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SGCM
Sand Grove Capital Management
London,
United Kingdom
|
+$9.16M |
| 2 |
CK
Carnick & Kubik
Colorado Springs,
Colorado
|
+$1.32M |
| 3 |
MAM
Mark Asset Management
New York
|
+$268K |
| 4 |
GIM
Grassi Investment Management
Santa Clara,
California
|
+$134K |
| 5 |
AWM
Altavista Wealth Management
Asheville,
North Carolina
|
+$76.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SL
Summitry LLC
Foster City,
California
|
-$20.4M |
| 2 |
III
Independent Investors Inc
Nesconset,
New York
|
-$1.72M |
| 3 |
DAM
Doheny Asset Management
Los Angeles,
California
|
-$230K |
| 4 |
TFA
Toth Financial Advisory
Leesburg,
Virginia
|
-$223K |
| 5 |
RCM
Reynolds Capital Management
Las Vegas,
Nevada
|
-$219K |
AGN Hedge Fund Activity: Q1 2016 in Review
23 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q1 2016, worth a combined $22.3M — down 42% from $38.4M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of AGN and 3 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 7 added.
The largest buyer was Sand Grove Capital Management, opening a new position worth an estimated $9.16M. The largest seller was Summitry LLC, exiting entirely with an estimated $20.4M sold.
- 23 institutional investors held Allergan Inc (AGN) as of Q1 2016, down from 28 in Q4 2015.
- Funds reported $22.3M of Allergan Inc stock for Q1 2016, down 42% quarter-over-quarter.
- 3 funds opened new Allergan Inc positions in Q1 2016 and 7 closed out, a net change of -4 holders.
- The largest Allergan Inc buyer in Q1 2016 was Sand Grove Capital Management, an estimated $9.16M added.
- The largest Allergan Inc seller in Q1 2016 was Summitry LLC, an estimated $20.4M sold.
Based on aggregated 13F filings for Q1 2016.